Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

Nature Medicine

Volumn 12, Issue 12, 2006, Pages 1372-1379

  Loser, Karin ^a   Mehling, Annette ^a   Loeser, Stefanie ^b   Apelt, Jenny ^a   Kuhn, Annegret ^c   Grabbe, Stephan ^d   Schwarz, Thomas ^e   Penninger, Josef M ^b   Beissert, Stefan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; FLOW CYTOMETRY; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KERATINOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION; THYMECTOMY; THYMUS TRANSPLANTATION; ULTRAVIOLET RADIATION;

ANIMALS; AUTOIMMUNITY; CELL COUNT; DENDRITIC CELLS; EPIDERMIS; IMMUNE TOLERANCE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; RANK LIGAND; T-LYMPHOCYTES, REGULATORY; ULTRAVIOLET RAYS;

EID: 33845543666     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1518     Document Type: Article

References (46)

1. + regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J. Immunol. 171, 5760-5768 (2003).
2. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
3. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979 (2004).
4. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
5. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
6. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326 (1999).
7. Malek, T.R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167-178 (2002).
8. Papiernik, M., de Moraes, M.L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 Tcells: expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371-378 (1998).
9. + immunoregulatory Tcells that control autoimmune diabetes. Immunity 12, 431-440 (2000).
10. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003).
11. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
12. Mehling, A. et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194, 615-628 (2001).
13. Anderson, D.M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179 (1997).
14. Wong, B.R. et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25194 (1997).
15. Theill, L.E., Boyle, W.J. & Penninger, J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795-823 (2002).
16. Fata, J.E. et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103, 41-50 (2000).
17. Grabbe, S. & Schwarz, T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19, 37-44 (1998).
18. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
19. Laufer, T.M., DeKoning, J., Markowitz, J.S., Lo, D. & Glimcher, L.H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383, 81-85 (1996).
20. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
21. + as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA 99, 13031-13036 (2002).
22. Bruder, D. et al. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34, 623-630 (2004).
23. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400 (2002).
24. Cremer, I. et al. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 100, 3646-3655 (2002).
25. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
26. Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
27. Loser, K. et al. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15. Eur. J. Immunol. 34, 2022-2031 (2004).
28. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101, 4862-4869 (2003).
29. Salomon, B. et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194, 677-684 (2001).
30. Dombrecht, E.J. et al. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 24, 31-37 (2006).
31. Bynoe, M.S., Evans, J.T., Viret, C. & Janeway, C.A., Jr. Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis. Immunity 19, 317-328 (2003).
32. Geissmann, F. et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196, 417-430 (2002).
33. Scheinecker, C., McHugh, R., Shevach, E.M. & Germain, R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090 (2002).
34. Schwarz, A. et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 172, 1036-1043 (2004).
35. Kong, Y.Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323 (1999).
36. Ashcroft, A.J. et al. Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 19, 849-861 (2003).
37. + Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16, 183-191 (2002).
38. Kragballe, K. Vitamin D analogues in the treatment of psoriasis. J. Cell. Biochem. 49, 46-52 (1992).
39. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002).
40. Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I. & Hamid, Q.A. New insights into atopic dermatitis. J. Clin. Invest. 113, 651-657 (2004).
41. Kuhn, A. et al. Phototesting in lupus erythematosus: a 15-year experience. J. Am. Acad. Dermatol. 45, 86-95 (2001).
42. Vassar, R., Rosenberg, M., Ross, S., Tyner, A. & Fuchs, E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 1563-1567 (1989).
43. Loser, K. et al. FK506 controls CD40L-induced systemic autoimmunity in mice. J. Invest. Dermatol. 126, 1307-1315 (2006).
44. Loser, K. et al. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. 12, 1294-1304 (2005).
45. + regulatory T cells by interleukin(IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735 (2005).
46. Labeur, M.S. et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162, 168-175 (1999).